UNNECESSARY TESTS AND TREATMENTS IN LOW VALUE CRITICAL CARE
Dr Gerben Keijzers
Senior Staff Specialist Emergency Physician,
Gold Coast Hospital at Department of Health, Queensland &
Adjunct Professor, Honorary Professor of Emergency Medicine
Griffith University & Bond University,
Queensland, Australia
RESEARCHER PROFILE
Filmed in Southport, Queensland | January 2025
Dr Gerben Keijzers is a Senior Staff Specialist Emergency Physician at the Gold Coast University Hospital Emergency Department. Dr Keijzers balances half of his time between clinical work and academic duties, including teaching medical students and conducting research. His role also include being an honorary professor of emergency medicine at Bond University and is an associate professor at Griffith University.
Dr Keijzers completed a master’s degree in epidemiology and medical degree in Nijmegen, The Netherlands. He came to Australia in 2002 and completed his Fellowship in Emergency Medicine in 2008. He has a PhD in the quality of trauma care.
He works clinically, conducts clinical research and is a clinical supervisor for medical students on emergency medicine rotation. Over the past 15 years, Dr Keijzers has helped create seven research pillars focused on critical care studies, such as sepsis and antimicrobial stewardship.
His research focus includes low-value care, which is in the area of unnecessary tests and treatments with minimal benefits. Dr Keijzers has contributed to over 100 publications and more than 20 grant applications. Through his involvement in multi-site collaborative research projects, he encourages critical thinking and curiosity among clinical staff, striving to enhance both patient care and the efficiency of healthcare resources.
He is the former chair of the Queensland Emergency Research Collaborative, a member of the Clinical Trials Group of the Australasian College for Emergency Medicine, a member of the Research Advisory Committee for the Emergency Care Institute and is section editor for the peer-reviewed journal Emergency Medicine Australasia.
Note: Narrative adapted from University of Queensland website and interview
-
Clinical guidelines for diagnostics and early intervention in Primary Aldosteronism
Primary Aldosteronism (PA), or Conn Syndrome, is the most commonly under-diagnosed cause of high blood pressure affecting millions of people. Associate Professor Jun Yang’s goal is to facilitate the diagnosis of every case of PA and make treatment widely available to all communities including the disadvantaged.
-
Antimicrobial technologies & drug delivery platforms
Dr Aaron Elbourne is an ARC DECRA Fellow, Jack Brockhoff ECR Fellow, and Associate Professor within the School of Science at STEM Hub. A leader in nanomaterials, soft matter science, and interface research, Aaron’s work addresses critical challenges in health and the environment.
With a strong focus on translational research, Aaron’s work bridges the gap between fundamental science and practical applications. His leadership in creating innovative technologies, fostering academic-industry partnerships, and empowering future researchers underscores his commitment to advancing science and creating a meaningful impact.
-
Oral administration of insulin for Type 1 Diabetes
Huiwen Pang is a 3rd year PhD candidate in the Australian Institute for Bioengineering and Nanotechnology, University of Queensland, focusing on biomedical health research. Prior to commencing his PhD, Huiwen studied animal genetics in his Masters degree at Huazhong Agriculture University in China.
People with diabetes, especially Type 1 diabetes, largely rely on the insulin injections or insulin pumps to control their high blood glucose levels, which is painful and has a high risk of infections.
Huiwen Pang is conducting research on nano-based drug formulations for Type 1 diabetes treatment, with a focus on using nanomaterials to load insulin for oral administration and employing anti-apoptotic and anti-inflammatory approaches to mitigate damage to beta cells.
